AGT and endometrial cancer: Specifically, they examined the prevalence of RAS-related single-nucleotide polymorphisms and showed that AGT levels were less prevalent in women with endometrial cancer than in controls, and AGT caused the removal of angiotensin I; both are anti-angiogenic factors.